Astec LifeSciences DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	1.00×	1.00×	0.96×	0.76×	0.73×
	1.52×	1.64×	1.28×	1.46×	0.82×
	−12.0%	−11.0%	−28.8%	−9.2%	6.8%
	0.49×	0.49×	0.41×	0.47×	0.67×
	2.37×	2.41×	3.75×	2.64×	2.33×
	−21.0%	−21.3%	−54.3%	−12.7%	6.4%
	−25.9%	−25.9%	−44.6%	−11.9%	6.3%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ASTEC₹661.00

Astec LifeSciences Limited

· Chemicals

₹ CrorePeersPUNJABCHEM MOL IPL INSECTICID DHARMAJ BHARATRAS ADVANCE HERANBAMcap ₹1,473 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.73	0.76	0.96	1.00	1.00
Interest Burden (Pretax/EBIT) ×	0.82	1.46	1.28	1.64	1.52
EBIT Margin %	6.78	-9.20	-28.83	-11.03	-11.97
Asset Turnover ×	0.67	0.47	0.41	0.49	0.49
Financial Leverage (Assets/Equity) ×	2.33	2.64	3.75	2.41	2.37
ROE (5-step product, year-end total equity) %	6.37	-12.69	-54.33	-21.31	-21.05
ROE (owners' profit / average owners' equity) %	6.27	-11.90	-44.62	-25.88	-25.88

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.